Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of oral gimatecan rescue treatment in advanced or metastatic soft tissue sarcoma
2005-001951-39Phase 2Active
- Sponsor
- Leadiant Biosciences
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of gimatecan in soft tissue sarcoma (STS), sponsored by Leadiant Biosciences. Primary endpoint: Observed response rate. Started Sep 2005; status: active.
02
Drugs
gimatecan
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on 2005-001951-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001951-39.